Karen A. Cashmere

2022

In 2022, Karen A. Cashmere earned a total compensation of $582.6K as Chief Commercial Officer at ZyVersa Therapeutics.

Compensation breakdown

Option Awards$282,622
Salary$300,000
Total$582,622

Cashmere received $300K in salary, accounting for 51% of the total pay in 2022.

Cashmere also received $282.6K in option awards.

Rankings

In 2022, Karen A. Cashmere's compensation ranked 4,057th out of 5,616 executives tracked by ExecPay. In other words, Cashmere earned more than 27.8% of executives.

ClassificationRankingPercentile
All
4,057
out of 5,616
28th
Division
Manufacturing
2,287
out of 3,048
25th
Major group
Chemicals And Allied Products
1,103
out of 1,375
20th
Industry group
Drugs
1,033
out of 1,276
19th
Industry
Pharmaceutical Preparations
751
out of 924
19th
Source: SEC filing on September 9, 2024.

Cashmere's colleagues

We found two more compensation records of executives who worked with Karen A. Cashmere at ZyVersa Therapeutics in 2022.

2022

Stephen Glover

ZyVersa Therapeutics

Chief Executive Officer

2022

Peter Wolfe

ZyVersa Therapeutics

Chief Financial Officer

News

You may also like